Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Silibinin-loaded micelles significantly protect hair from UV-B damage.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Hair regrowth improved, but quality of life did not.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Early diagnosis and treatment of SLE are crucial to prevent severe complications.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Enhancing Tregs can protect against alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.